|
The result was announced after market hours yesterday, 26 May 2016.
Meanwhile, the S&P BSE Sensex was up 200.07 points or 0.76% at 26,566.75.
On BSE, so far 28,000 shares were traded in the counter as against average daily volume of 4,426 shares in the past one quarter. The stock hit a high of Rs 192.20 and a low of Rs 186.15 so far during the day. The stock had hit a 52-week high of Rs 273.80 on 6 October 2015. The stock had hit a 52-week low of Rs 145.10 on 12 June 2015. The stock had outperformed the market over the past one month till 26 May 2016, advancing 1.61% compared with Sensex's 1.38% rise. The scrip had, however, underperformed the market in past one quarter, gaining 0.99% as against Sensex's 13.87% rise.
The mid-cap company has equity capital of Rs 17.78 crore. Face value per share is Rs 1.
FDC is a pharmaceutical research and development company, which specializes in the areas of synthetics (basic drugs), nutraceuticals, formulations and biotechnology products.
|